1887
2 - Qatar Health 2021 Conference abstracts
  • ISSN: 1999-7086
  • EISSN: 1999-7094

Abstract

Human immunodeficiency virus (HIV) infection remains a major health problem since discovery of the virus in 19811,2. Globally, since the introduction of antiretroviral therapy in 1996, acquired immunodeficiency syndrome (AIDS) related deaths fell by more than 25% between 2005 and 2011. HIV related opportunistic illnesses (OIs) are less common, especially with the use of prophylaxis3. This study aims to assess the incidence of HIV infection and related OIs in Qatar over a 17-year period. This is a retrospective cohort study of all HIV infected patients registered in Qatar from 2000-2016. Incidence of HIV infection and related OIs were calculated per 100,000 population. Demographic and clinical characteristics were compared between two groups of patients with and without OIs. In 167 cases with HIV infection, 54 (32.3%) had OIs. The average incidence rate of HIV infection over 16 years is 0.69 per 100,000 population, and the incidence rate for OIs is 0.27 per 100,000 population (Figure 1). The most common OIs is pneumocystis jirovecii pneumonia (PCP), seen in 25% of cases, followed by cytomegalovirus (CMV) retinitis with 7.2%, tuberculosis 5.4%, toxoplasmosis 4.2%, and less than 2% for Kaposi sarcoma and cryptococcal infection. The treatment outcome of cases with OIs was: cure in 59.3%, failure in 3.7%. Mortality within 3 months of OIs was 3.7%, whereas 33.4% accounted for loss to follow up after starting the treatment due to patients leaving the country. Most patients in both groups were young males. The CD4 lymphocyte count and percentage (CD4%), CD4/CD8 ratio and viral load were statistically significant risk factors in cases with OIs (p < 0.05). Presence of comorbidities was lower in patients with OIs (p = 0.032) (Table 1). Qatar has a low prevalence rate for HIV infection and related opportunistic illness. Early diagnosis and use of antiretroviral therapy are important measures to decrease the rate of opportunistic illness.

Loading

Article metrics loading...

/content/journals/10.5339/jemtac.2021.qhc.29
2021-09-13
2024-04-19
Loading full text...

Full text loading...

/deliver/fulltext/jemtac/2021/2/jemtac.2021.qhc.29.html?itemId=/content/journals/10.5339/jemtac.2021.qhc.29&mimeType=html&fmt=ahah

References

  1. Jones JL, Hanson DL, Dworkin MS, Alderton DL, Fleming PL, Kaplan JE, et al. Surveillance for AIDS-defining opportunistic illnesses, 1992–1997. Arch Dermatol. 1999; 135:(8):897–902.
    [Google Scholar]
  2. Al Soub H, Al-khal AL, Al Maslamani M, Dousa K, Ahmed A, Fabella A. Epidemiology and the Changing Face of HIV Infection in Qatar. Infectious Diseases in Clinical Practice. 2018; 26:(4):220–3.
    [Google Scholar]
  3. Balkhair AA, Al-Muharrmi ZK, Ganguly S, Al-Jabri AA. Spectrum of AIDS defining opportunistic infections in a series of 77 hospitalised HIV-infected Omani patients. Sultan Qaboos Univ Med J. 2012; 12:(4):442–8.
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journals/10.5339/jemtac.2021.qhc.29
Loading
/content/journals/10.5339/jemtac.2021.qhc.29
Loading

Data & Media loading...

  • Article Type: Conference Abstract
Keyword(s): AIDSCD4 counthepatitis co-infectionsopportunistic illness and viral load
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error